U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07169916) titled 'Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer' on Aug. 21.
Brief Summary: This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the impact of Yueju Pill on quality of life and treatment efficacy in patients with advanced biliary tract cancer (BTC) receiving standard therapy.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Biliary Tract Cancer (BTC)
Intervention:
DRUG: Yueju Pill + Standard Anti-tumor Therapy
Group A (Intervention): Standard therapy + Yueju Pill (6-9 g per dose, twice daily, orally until disease progression o...